GMED Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Globus Medical Inc (GMED) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, consistent analyst optimism, and bullish technical indicators outweigh the lack of recent news and insider selling. Despite minor short-term price fluctuations, GMED demonstrates solid growth potential and long-term value.
The technical indicators for GMED are bullish. The MACD is positive and contracting, indicating upward momentum. The RSI is neutral at 59.406, and the moving averages show a bullish trend (SMA_5 > SMA_20 > SMA_200). Key support is at 86.633, and resistance is at 95.083, suggesting the stock is trading near a potential breakout level.
Strong Q4 2025 financial performance with revenue up 25.73% YoY, net income up 430.44% YoY, and EPS up 442.11% YoY.
Analysts consistently raising price targets, with the highest at $123, and maintaining Buy/Overweight ratings.
Bullish technical indicators and a 7.84% chance of price appreciation in the next month.
Insiders have significantly increased selling activity (up 389.20% in the last month).
No recent news or event-driven catalysts.
Short-term stock trend analysis suggests a potential -2.47% decline in the next week.
In Q4 2025, Globus Medical reported impressive financial growth: revenue increased by 25.73% YoY to $826.42M, net income surged by 430.44% YoY to $140.59M, EPS grew by 442.11% YoY to 1.03, and gross margin improved to 64.85%, up 17.12% YoY.
Analysts are highly optimistic about GMED, with multiple firms raising price targets (ranging from $104 to $123) and maintaining Buy/Overweight ratings. Analysts highlight strong financial performance, growth in US Core Spine, and long-term earnings potential as key drivers for the stock's future performance.
